Effect of Topical Nasal Decongestants on Nasal Peak Flow Rates in Adults Suffering from Acute Sinusitis
Main Article Content
Abstract
INTRODUCTION
In this research we study the effect of Nasal decongestant Xylometazoline 0.1% solution on Serial measurements of Nasal peak flow rates in a cohort of patients who were suffering from Acute Sinusitis.
CASE SERIES
A population of 90 patients were chosen from our regular Out-patient clinics who were suffering from Acute Sinusitis based on a Clinical diagnostic criterion. A baseline Nasal peak Flowmetry was done before and this was followed by common Decongestant Xylometazoline 0.1% solution spray application, followed by serial readings of Nasal peak Flowmetry done after 10 minutes, 25 minutes, 60 minutes, 120 minutes,240 minutes and 360 was taken then plotted and analysed.
DISCUSSION
From the A.U.C Curves it can be inferred that Maximum decongestant action of Xylometazoline 0.1% solution is seen 1 hour after application and the raise in decongestant reaches a plateau by 2 hours. Readings remain elevated from baseline well 6 hours post decongestion.
CONCLUSION
Patients who are prescribed Xylometazoline 0.1% solution are advised that maximum relief from congestion would be obtained around 1 to 2 hours after application and hence effect would decrease. Surgeons who use Xylometazoline 0.1% solution for nasal packing must proceed with the Surgery within 1 hour of application of the pack to obtain maximum hemostatic and decongestant benefit of this drug.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
REFERENCES
Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its etiology, evaluation,
and treatment. Ear Nose Throat J. 2000; 79: 690-693
Holmstrom M. The use of objective measures in selecting patients for septal surgery.
Rhinology. 2010; 48: 387-393
PDR Physicians' desk reference for non prescription drugs. 19th ed. 1998. Montvale, NJ:
Medical Economics Co Inc; 1998. p. 704.
Bende M, fukami M, Arfors Keet al. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit. Annals of Otorhinolaryngology 1996; 105:222–5.
Gillis MC, editor. CPS Compendium of pharmaceuticals and specialties. 34th ed. Ottawa:
Canadian Pharmacists Association; 1999. p. 469
Pearlman A, Conley D. Review of current guidelines related to the diagnosis and treatment of Rhinosinusitis. Current Opinion in Otolaryngology Head and Neck Surgery 2008; 16:226–30
Clarke RW, Jones AS. The limitations of peak nasal flow measurement. Clinical Otolaryngology Allied Sci. 1994; 19: 502-504
Lacy CF, Armstrong LL, Ingrim NB, et al. editors. A PhA Drug information handbook. 6th
ed. Cleveland: Lexi-Corp Inc; 1998. p. 764.
Ottaviano G, Scadding GK, Scarpa B, Accordi D, Staffieri A, Lund VJ. Unilateral peak nasal
inspiratory flow, normal values in adult population. Rhinology. 2012; 50: 386-392
Hammer, Ø., Harper, D.A.T., Ryan, P.D. 2001. PAST: Paleontological statistics software package for education and data analysis. Palaeontologia Electronica 4(1): 9pp.